EPISODE · Aug 28, 2025 · 10 MIN
How Immunotherapy is Transforming Lung Cancer Treatment: Hope, Benefits, and What to Expect
In this episode, we explore how immunotherapy is revolutionizing lung cancer treatment and giving patients new hope. Unlike chemotherapy and radiation, immunotherapy trains your immune system to recognize and attack cancer cells, often with fewer side effects and longer-lasting results.You’ll learn:What makes immunotherapy different from traditional lung cancer treatmentsHow immune checkpoint inhibitors help your body target tumor cellsWhich patients may be eligible for immunotherapy, and why PD-L1 testing mattersThe key benefits for patients include improved survival rates and quality of lifeCommon side effects and how doctors help you manage themExciting advances in research, including combination therapies and cancer vaccinesImmunotherapy is not just a new option; it’s a game-changing approach that’s transforming the future of lung cancer care.Blog Link: How Immunotherapy is Revolutionizing Lung Cancer TreatmentSend us Fan MailThank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education.Author: Dr. CHRISTINA NG VAN TZE📍 Visit us at oncolifecentre.com 📞 Call: +603-2242-2620 📧 Book a consultation or ask a question — we're here to support your journey.
What this episode covers
In this episode, we explore how immunotherapy is revolutionizing lung cancer treatment and giving patients new hope. Unlike chemotherapy and radiation, immunotherapy trains your immune system to recognize and attack cancer cells, often with fewer side effects and longer-lasting results. You’ll learn: What makes immunotherapy different from traditional lung cancer treatmentsHow immune checkpoint inhibitors help your body target tumor cellsWhich patients may be eligible for immunotherapy, and w...
NOW PLAYING
How Immunotherapy is Transforming Lung Cancer Treatment: Hope, Benefits, and What to Expect
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m